Roche Eesti Osaühing

Year	Period	Submitted	Status
2025	01.01.2025 – 31.12.2025	30.06.2026	Valid	PDF
2024	01.01.2024 – 31.12.2024	18.06.2025	Valid	PDF
2023	01.01.2023 – 31.12.2023	11.06.2024	Valid	PDF
2022	01.01.2022 – 31.12.2022	26.06.2023	Valid	PDF
2021	01.01.2021 – 31.12.2021	27.06.2022	Valid	PDF
2020	01.01.2020 – 31.12.2020	07.05.2021	Valid	PDF
2019	01.01.2019 – 31.12.2019	07.08.2020	Valid	PDF
2018	01.01.2018 – 31.12.2018	10.05.2019	Valid	PDF
2017	01.01.2017 – 31.12.2017	19.04.2018	Valid	PDF
2016	01.01.2016 – 31.12.2016	03.04.2017	Valid	PDF
2015	01.01.2015 – 31.12.2015	19.04.2016	Valid	PDF
2014	01.01.2014 – 31.12.2014	06.04.2015	Valid	PDF
2013	01.01.2013 – 31.12.2013	12.06.2014	Valid	PDF
2012	01.01.2012 – 31.12.2012	25.06.2013	Valid	PDF
2011	01.01.2011 – 31.12.2011	27.06.2012	Valid	PDF
2010	01.01.2010 – 31.12.2010	01.07.2011	Valid	PDF
2009	01.01.2009 – 31.12.2009	29.06.2010	Valid	PDF
2008	01.01.2008 – 31.12.2008	03.07.2009	Valid	PDF
2007	01.01.2007 – 31.12.2007	01.07.2008	Valid	PDF
2006	01.01.2006 – 31.12.2006	02.07.2007	Valid	PDF
2005	01.01.2005 – 31.12.2005	04.07.2006	Valid	PDF

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 24.10.2026.

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions–Official announcements–TTJA decisions–Real estate–.ee domains7 Licenses–Regulations42 Public transactions2336 Grants–State aid1 Public procurement423 Holdings in companies–Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q3	1,64 M €	290 661 €	22,9 M €+109%	36
2026 Q2	879 357 €	706 481 €	10,9 M €−38,6%	36
2026 Q1	1,11 M €	399 739 €	17,8 M €+39,8%	39
Total 2026:	3,62 M €	1,40 M €	51,7 M €
2025 Q4	519 593 €	302 405 €	12,7 M €−24,8%	41
2025 Q3	1,28 M €	374 337 €	17,0 M €+68,5%	42
2025 Q2	954 291 €	714 607 €	10,1 M €−51,8%	39
2025 Q1	1,02 M €	302 605 €	20,9 M €+91,3%	40
Total 2025:	3,78 M €	1,69 M €	60,7 M €
2024 Q4	511 203 €	276 622 €	10,9 M €−45,4%	41
2024 Q3	1,01 M €	321 168 €	20,0 M €+29,4%	42
2024 Q2	1,02 M €	544 280 €	15,4 M €+7,5%	40
2024 Q1	710 768 €	262 914 €	14,4 M €−3,1%	40
Total 2024:	3,26 M €	1,40 M €	60,7 M €
2023 Q4	622 566 €	222 731 €	14,8 M €+23,8%	42
2023 Q3	596 319 €	298 660 €	12,0 M €−12,0%	39
2023 Q2	917 477 €	546 489 €	13,6 M €−18,7%	41
2023 Q1	664 163 €	243 973 €	16,7 M €+17,7%	46
Total 2023:	2,80 M €	1,31 M €	57,1 M €
2022 Q4	511 529 €	246 443 €	14,2 M €+22,4%	50
2022 Q3	573 875 €	266 825 €	11,6 M €−29,6%	57
2022 Q2	884 006 €	484 158 €	16,5 M €+41,1%	57
2022 Q1	594 342 €	227 274 €	11,7 M €+25,5%	58
Total 2022:	2,56 M €	1,22 M €	54,0 M €
2021 Q4	489 346,08 €	212 227,34 €	9,32 M €−28,5%	59
2021 Q3	463 371,51 €	252 542,59 €	13,0 M €+21,3%	60
2021 Q2	758 353,36 €	375 587,05 €	10,7 M €+5,0%	60
2021 Q1	520 910,96 €	199 058,51 €	10,2 M €−17,8%	60
Total 2021:	2,23 M €	1,04 M €	43,3 M €
2020 Q4	483 769,32 €	195 035,48 €	12,4 M €+50,3%	66
2020 Q3	630 823,71 €	242 931,07 €	8,29 M €−26,7%	66
2020 Q2	779 322,77 €	452 861,62 €	11,3 M €+19,8%	64
2020 Q1	490 764 €	188 776 €	9,44 M €+13,7%	58
Total 2020:	2,38 M €	1,08 M €	41,5 M €
2019 Q4	501 494 €	172 336 €	8,30 M €+14,9%	61
2019 Q3	494 831 €	201 378 €	7,22 M €+5,0%	60
2019 Q2	711 423 €	377 874 €	6,88 M €−35,7%	60
2019 Q1	586 800 €	204 215 €	10,7 M €+20,0%	60
Total 2019:	2,29 M €	955 803 €	33,1 M €
2018 Q4	802 965 €	164 673 €	8,91 M €+9,4%	70
2018 Q3	656 270 €	201 017 €	8,15 M €−7,7%	71
2018 Q2	796 956 €	378 768 €	8,83 M €−6,9%	69
2018 Q1	657 523 €	185 788 €	9,48 M €+15,8%	64
Total 2018:	2,91 M €	930 246 €	35,4 M €
2017 Q4	644 536 €	154 751 €	8,19 M €+16,6%	88
2017 Q3	673 251 €	196 400 €	7,02 M €+8,4%	80
2017 Q2	765 255 €	370 677 €	6,48 M €−11,4%	80
2017 Q1	882 797 €	176 015 €	7,32 M €+48,2%	80
Total 2017:	2,97 M €	897 843 €	29,0 M €
2016 Q4	670 446 €	143 752 €	4,94 M €−15,1%	24
2016 Q3	916 832 €	169 319 €	5,82 M €−45,3%	24
2016 Q2	857 431 €	309 694 €	10,6 M €+93,2%	24
2016 Q1	773 037 €	160 332 €	5,51 M €+27,8%	24
Total 2016:	3,22 M €	783 097 €	26,9 M €
2015 Q4	626 250 €	154 439 €	4,31 M €−15,6%	23
2015 Q3	699 274 €	182 880 €	5,10 M €−51,2%	23
2015 Q2	1,02 M €	374 636 €	10,4 M €+128%	23
2015 Q1	846 967 €	164 094 €	4,58 M €	23
Total 2015:	3,20 M €	876 049 €	24,4 M €

Revenue by industry

	2023	2024	2025
All other professional, scientific and technical activities n.e.c.		27 104 000 €	31 253 000 €
Wholesale of other intermediate products	15 212 000 €	16 834 000 €	17 193 000 €
Other professional, scientific and technical activities n.e.c.	22 223 000 €

Tax debts

No tax debt found

No tax debt as of 24.10.2026

Representatives

	Personal ID code
Juan Cortizo	-	27.07.1975 (51)	Board member	11.10.2022	-
Mart Vain	38603XXXXXX	04.03.1986 (40)	Procurator	28.06.2022	-
Martin-Kaspar Sild	38905XXXXXX	10.05.1989 (37)	Procurator	06.04.2020	-
Ehab Youssef	A2405XXXX	-	Board member	18.02.2020	-
Kea Kapsta	47201XXXXXX	26.01.1972 (54)	Procurator	08.11.2017	-

22 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Shareholders

	Personal ID code
Roche Finanz AG	-	-	Shareholder	127 823 EUR	100,00%	Sole ownership	01.09.2023	-

22 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Other persons

	Personal ID code
KPMG Baltics OÜ	10096082	22.11.1996 (29)	Audit firm	16.10.2017	-
Andris Jegers	37003XXXXXX	18.03.1970 (56)	Audit firm	03.04.2017	-
Roche Finanz AG	-	-	Founder	15.04.2005	-

22 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Mart Vain	38603XXXXXX	04.03.1986 (40)	Other form of control/influence (contractual, family etc.)	12.10.2022	-
Kea Kapsta	47201XXXXXX	26.01.1972 (54)	Other form of control/influence (contractual, family etc.)	09.04.2021	-
Martin-Kaspar Sild	38905XXXXXX	10.05.1989 (37)	Other form of control/influence (contractual, family etc.)	09.04.2021	-

22 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

2026 Q3

Turnover

Amount: 22 928 752 €
Monthly average: 7 642 917 €
Per employee: 212 303 €
Equity ratio: 5 979,30%

Labour taxes

Turnover ratio: 1,27%
Tax ratio: 17,74%
Monthly average: 96 887 €
Per employee: 2 691 €

State taxes

Monthly average: 546 266 €
Turnover ratio: 7,15%

Estimated salary

Gross salary: 4 783 €
Net salary: 3 751 €

Aggregate data

Last 5 yrsAll

	2025	2024	2023	2022	2021	2020	2019
Current assets	37 438 000 €+41,0%	26 558 000 €+23,7%	21 467 000 €+15,4%	18 602 000 €+1,5%	18 327 000 €+7,1%	17 110 000 €+12,0%	15 270 000 €
Non-current assets	464 000 €−26,3%	630 000 €+13,7%	554 000 €−16,8%	666 000 €+3,1%	646 000 €+3,9%	622 000 €+1,8%	611 000 €
Total assets	37 902 000 €+39,4%	27 188 000 €+23,5%	22 021 000 €+14,3%	19 268 000 €+1,6%	18 973 000 €+7,0%	17 732 000 €+11,7%	15 881 000 €
Short-term liabilities	24 163 000 €+70,0%	14 215 000 €+19,0%	11 945 000 €+18,0%	10 123 000 €−8,3%	11 042 000 €+1,4%	10 885 000 €+12,1%	9 710 000 €
Long-term liabilities	178 000 €−40,5%	299 000 €+16,8%	256 000 €−24,0%	337 000 €+12,0%	301 000 €+21,4%	248 000 €−36,6%	391 000 €
Total liabilities	24 341 000 €+67,7%	14 514 000 €+19,0%	12 201 000 €+16,6%	10 460 000 €−7,8%	11 343 000 €+1,9%	11 133 000 €+10,2%	10 101 000 €
Share or stock capital	-	-	-	-	-	-	-
Retained earnings	10 337 000 €+9,0%	9 484 000 €+26,2%	7 517 000 €+18,6%	6 339 000 €+19,4%	5 308 000 €+18,2%	4 489 000 €+17,5%	3 822 000 €
Net profit	1 867 000 €	1 867 000 €+84,5%	1 012 000 €−14,1%	1 178 000 €+14,3%	1 031 000 €+25,9%	819 000 €+22,8%	667 000 €
Equity	13 561 000 €+7,0%	12 674 000 €+29,1%	9 820 000 €+11,5%	8 808 000 €+15,4%	7 630 000 €+15,6%	6 599 000 €+14,2%	5 780 000 €
Turnover	48 446 000 €+10,3%	43 938 000 €+17,4%	37 435 000 €−0,3%	37 547 000 €+20,8%	31 074 000 €+5,3%	29 521 000 €+14,7%	25 743 000 €
Profit margin	3,9%	4,2%	2,7%	3,1%	3,3%	2,8%	2,6%

Financial ratios

	2022	2021
Profit and cash flow
EBITDA	1 435 000 €	1 258 000 €
Liquidity
Current ratio	1,8	1,7
Quick ratio	0,8	0,5
Cash ratio	0,0	0,0
Efficiency
Days sales outstanding (dso)	63,9	61,8
Asset turnover	2,0	1,7
Structure
Debt ratio	0,5	0,6
Profitability
Operating margin	3,2%	3,3%
Net profit margin	3,1%	3,3%
Return on assets (roa)	6,2%	5,6%
Return on equity (roe)	13,4%	13,5%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations


Ä 10087892 / 33	24.03.2026	Entry – Amendment entry	-	Entered into force24.03.2026
Ä 10087892 / M9	27.02.2026	Order to remedy deficiencies – Amendment entry	11.04.2026	Deficiencies remedied24.03.2026
Ä 10087892 / 32	03.10.2025	Entry – Amendment entry	-	Entered into force03.10.2025
Ä 10087892 / 31	01.09.2023	Entry – Amendment entry	-	Entered into force01.09.2023
Ä 10087892 / 30	11.10.2022	Entry – Amendment entry	-	Entered into force11.10.2022

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions

No court decisions found

The company has no court decisions

Official announcements

No official announcements found

Company has no issued official announcements

Public transactions


30.09.2026	Aktsiaselts Lääne-Tallinna Keskhaigla	1 944,02 €Received	OPERATING EXPENSESSpecialized hospital services
25.09.2026	sihtasutus Põhja-Eesti Regionaalhaigla	30 949,46 €Received	OPERATING EXPENSESSpecialized hospital services
25.09.2026	sihtasutus Põhja-Eesti Regionaalhaigla	5 182,19 €Received	OPERATING EXPENSESSpecialized hospital services
25.09.2026	sihtasutus Põhja-Eesti Regionaalhaigla	142 043,46 €Received	OPERATING EXPENSESSpecialized hospital services
25.09.2026	sihtasutus Tartu Ülikooli Kliinikum	342 704,83 €Received	OPERATING EXPENSESGeneral hospital services

Funded projects

No funded projects found

The company has no projects funded by EU or foreign grants

State aid


04.12.2023	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 231469	Koolitus VTA › Koolitus VTAGrant	1 420 €	231469/2400006

Public procurement contracts


24.09.2026End 30.06.2027	Reference number 315249 · 315249 osa 5 Haiglaravimid - september 2026 Roche Eesti OÜ	sihtasutus Põhja-Eesti RegionaalhaiglaContracting authority	125 280 €	Concluded
30.07.2026End 30.07.2027	Reference number 311634 · Raamleping osa 4	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	200 000 €	Concluded
30.07.2026End 30.07.2027	Reference number 312678 · Raamleping	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	1 200 000 €	Concluded
11.06.2026End 31.07.2027	Reference number 308199 · MÜÜGILEPING nr 3-7/2218-1	Aktsiaselts Lääne-Tallinna KeskhaiglaContracting authority	228 533 €	Concluded
26.03.2026End 31.03.2028	Reference number 304907 · Ravimi müügi raamleping, osad 12, 13, 18, 19, 20	sihtasutus Tartu Ülikooli KliinikumContracting authority	6 543 310,28 €	Concluded

.ee domains


tarkpatsient.ee	Active	27.10.2021	28.10.2027
hemonitor.ee	Active	19.02.2021	20.02.2027
foundationmedicine.ee	Active	11.02.2021	12.02.2027
sclerosismultiplex.ee	Active	01.07.2020	02.07.2027
floodlightopen.ee	Active	23.12.2019	24.12.2026

1 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.